This is a dynamic purchasing system or similar standing arrangement, not a one-off tender.
Suppliers can apply to join at any time until 31 March 2027. The buyer then invites admitted suppliers to compete for individual contracts, each with its own short deadline.
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-12 - Tofacitinib
Germany – Pharmaceutical products – Open House Original Discount Contracts 2024-12 - TofacitinibEnglish, machine translated
Issued by Techniker Krankenkasse · via TED — Tenders Electronic Daily (EU)
- Published
- 6 Nov 2026
- Open to join until
- 31 Mar 2027, 23:59 UTC
- Reference
- 772079-2026
- Location
- Germany
- Sector
- Healthcare & Pharma
- Type
- goods
At a glance
Techniker Krankenkasse in Germany has published an open-admission purchasing arrangement in healthcare & pharma: “Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-12 - Tofacitinib”. Suppliers can apply to join until 31 March 2027. Quote reference 772079-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 83 notices from this buyer since 2026, 60 of them currently open. There are 775 open healthcare & pharma notices in Germany on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.
English summary
Machine translated from German by FreeTender. The original notice below is the binding text.
TK pursues the goal of concluding discount contracts with all suitable pharmaceutical companies in accordance with § 130c para 1 SGB V on the active ingredient tofacitinib. The contract is concluded within the framework of the Open House Original procedure of the TK: Individual negotiations on contract contents are not conducted, uniform conditions apply. TK does not guarantee individual contractual partners exclusivity. The contract period is a maximum of 28 months starting from 01.01.2025. The contract ends at the latest on 31.03.2027, regardless of the date of conclusion of the contract.
Details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zum Wirkstoff Tofacitinib zu schließen. Der Vertragsschluss erfolgt im Rahmen des Open-House-Originale-Verfahrens der TK: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die TK sichert einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 28 Monate beginnend mit dem 01.01.2025. Der Vertrag endet spätestens am 31.03.2027, unabhängig vom Datum des Vertragsschlusses. Bei Patentablauf/Ablauf der Marktexklusivität vor dem o.g. Enddatum endet der Vertrag automatisch mit Ablauf des Monats des Patentablaufs/der Marktexklusivität. Ein Beitritt zu diesem Open-House-Originale-Verfahren ist innerhalb der Vertragslaufzeit jederzeit möglich. Aufgrund des Bestehens von gewerblichen Schutzrechten im Hinblick auf den vertragsgegenständlichen Wirkstoff bzw. die verfahrensgegenständliche Wirkstoffkombination werden die Teilnahme- und Vertragsunterlagen nur solchen pharmazeutischen Unternehmern zur Verfügung gestellt, die Arzneimittel zu dem verfahrensgegenständlichen Wirkstoff bzw. der verfahrensgegenständlichen Wirkstoffkombination anbieten/inverkehrbringen bzw. gegenüber der TK glaubhaft machen, solche Arzneimittel innerhalb der Vertragslaufzeit anbieten/inverkehrbringen zu wollen. Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen.
Lots Lot 1 — Open House Originale Rabattverträge 2024-12 - Tofacitinib: Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zum Wirkstoff Tofacitinib zu schließen.
Buyer: Techniker Krankenkasse
Buyer country: DEU
Procedure: open
CPV code: 33600000
Full notice, tender documents and how to bid are on the official TED page (link above).
Context for bidders
We hold 83 notices from Techniker Krankenkasse, going back to August 2026 — 60 of them still open. They buy mostly in Healthcare & Pharma, IT & Telecom and Construction & Infrastructure. There are 775 open Healthcare & Pharma tenders in Germany. This one closes in 146 days.
More from this buyer
- Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 34 Imiglucerase· closes 31 Dec
- Germany – Building-cleaning services – Gebäudereinigung 21· closes 17 Dec
- Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-33 Pertuzumab / Trastuzumab (Wirkstoffkombination)· closes 31 Dec
- Germany – Pharmaceutical products – Open-House-Rabattverträge 2026-21 Lisdexamfetamin (90 St.)· closes 31 Mar
- Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)· closes 30 Nov
Similar Healthcare & Pharma tenders
- Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-33 Pertuzumab / Trastuzumab (Wirkstoffkombination)· closes 31 Dec
- Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 34 Imiglucerase· closes 31 Dec
- Germany – General-practitioner services – Rahmenvertrag über die Durchführung der zweiten Leichenschau· closes 12 Nov
- Germany – Miscellaneous health services – Antidekubitusmatratzen zur Miete für den Landschaftsverband Rheinland· closes 7 Dec
- Germany – Toilet paper, handkerchiefs, hand towels and serviettes – Verbrauchsmittel Sanitär· closes 7 Dec
Documents
- TED-official-notice-772079-2026.pdfDownload (pdf)
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- To facilitate construction of X-RAY block at GWANUMPU health centre in Kakonko District Council by june 2027KAKONKO DISTRICT COUNCIL · Tanzania
- Completion of Construction of Wards at Mchemo District HospitalNEWALA DISTRICT COUNCIL · Tanzania
- Provision of Catering Services at TMDA HQ OfficeTANZANIA MEDICINES AND MEDICAL DEVICES AUTHORITY · Tanzania
- Supply of tablets computerLAW REFORM COMMISSION OF TANZANIA · Tanzania
- Аптечки автомобильныеИКИР ДВО РАН · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →